An oncogenic role for miR-382-5p has been previously reported in gastric cancer through targeting of PTEN [22]; however, contrary progression-suppressive roles of miR-382-5p have been reported in different cancer types by targeting genes of distinct pathways [23–26]. Here, PTEN is linked to gastric cancer.